Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 193 Records) |
| Query Trace: DNA Damage and Tp53[original query] |
|---|
| Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis. Open life sciences 2023 7 18 (1): 20220652. Jianbo Peng, Shuo Fang, Meisheng Li, Yuxin Liu, Xiaolu Liang, Zuobiao Li, Gaohui Chen, Lijiao Peng, Nianping Chen, Lei Liu, Xiaohong Xu, Wei D |
| Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. Human genomics 2023 7 17 (1): 66. Ning-Yuan Lee, Melissa Hum, Sabna Zihara, Lanying Wang, Matthew K Myint, Darren Wan-Teck Lim, Chee-Keong Toh, Anders Skanderup, Jens Samol, Min-Han Tan, Peter Ang, Soo-Chin Lee, Eng-Huat Tan, Gillianne G Y Lai, Daniel S W Tan, Yoon-Sim Yap, Ann S G L |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Cancer medicine 2023 6 . Xiaoling Duan, Man Zhao, Xiaolei Yin, Lili Mi, Jianfei Shi, Ning Li, Xin Han, Guangjie Han, Jinfeng Wang, Jiaojiao Hou, Fei Y |
| [FARSB stratifies prognosis and cold tumor microenvironment across different cancer types: an integrated single cell and bulk RNA sequencing analysis]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2023 6 43 (5): 667-679. Ziran Zhang, Jiale Tan, Zihang Yu, Chengdong Liu, Jian Wang, Dehua Wu, Xue B |
| Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology 2023 5 81 (20): 1996-2009. Esra D Gumuser, Art Schuermans, So Mi Jemma Cho, Zachary A Sporn, Md Mesbah Uddin, Kaavya Paruchuri, Tetsushi Nakao, Zhi Yu, Sara Haidermota, Whitney Hornsby, Lachelle D Weeks, Abhishek Niroula, Siddhartha Jaiswal, Peter Libby, Benjamin L Ebert, Alexander G Bick, Pradeep Natarajan, Michael C Honigbe |
| Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing. Anticancer research 2023 4 43 (5): 1891-1900. Joanna Lopacinska-Joergensen, Douglas V N P Oliveira, Tim Svenstrup Poulsen, Claus K Hoegdall, Estrid V Hoegda |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer medicine 2023 4 . Wei Huang, Wenliang Li, Ning Xu, Hui Li, Zihan Zhang, Xiaolong Zhang, Tingting He, Jicheng Yao, Mian Xu, Qingqing He, Lijie Guo, Sen Zha |
| Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
| SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis. Molecular cancer 2023 3 22 (1): 52. Njouendou Abdel Jelil, Szarvas Tibor, Tiofack Arnol Auvaker Zebaze, Kenfack Rovaldo Nguims, Tonouo Pamela Derliche, Ananga Sidonie Noa, Bell Esther H M Dina, Simo Gustave, Hoheisel Jörg D, Siveke Jens T, Lueong Smiths |
| Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients. Frontiers in oncology 2023 2 12 1086908. Jia Bin, Xia Peiyi, Dong Junqiang, Feng Wenhao, Wang Wenjia, Liu Enjie, Jiang Guozhong, Qin Yan |
| Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased. JCI insight 2023 2 . Tague Laneshia K, Oetjen Karolyn A, Mahadev Anirudh, Walter Matthew J, Anthony Hephzibah, Kreisel Daniel, Link Daniel C, Gelman Andrew |
| The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
| DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
| Gradual transition towards anaplasia in Wilms tumor through tolerance to genetic damage. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 11 100382. Kaname Uno, Bahar Rastegar, Caroline Jansson, Geoffroy Durand, Anders Valind, Subhayan Chattopadhyay, Alessia Bertolotti, Sara Ciceri, Filippo Spreafico, Paola Collini, Daniela Perotti, Linda Holmquist Mengelbier, David Gisselss |
| DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients. Cancers 2023 10 15 (20): . Dorota Butkiewicz, Ma?gorzata Krze?niak, Agnieszka Gdowicz-K?osok, Krzysztof Sk?adowski, Tomasz Rutkows |
| Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer. NPJ precision oncology 2024 9 8 (1): 214. Jingyuan Wang, Joanne Xiu, Francesca Battaglin, Hiroyuki Arai, Shivani Soni, Wu Zhang, Richard M Goldberg, Philip A Philip, Andreas Seeber, Jimmy J Hwang, Anthony F Shields, John L Marshall, Igor Astaturov, Tianshu Liu, A Craig Lockhart, W Michael Korn, Lin Shen, Heinz-Josef Le |
| TP53 Gene Polymorphism (Rs1042522) in Rheumatoid Arthritis and Systemic Lupus Erythematosus: An Updated Systematic Review and Meta-Analysis. Current rheumatology reviews 2024 9 . Hamidreza Ebrahimiyan, Elham Madreseh, Maryam Akhtari, Elham Farhadi, Ahmadreza Jamshidi, Mahdi Mahmou |
| PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes. Cancer genomics & proteomics 2024 8 21 (5): 533-548. Ioannis A Voutsadak |
| The Impact of Li Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes and Genetic Testing Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 8 . Josephine K Dermawan, David H Abramson, Sarah Chiang, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Diana Mandelker, Cristina R Antones |
| Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma. Cancer science 2024 7 . Kazuchika Nishitsuji, Remi Mito, Midori Ikezaki, Hiromu Yano, Yukio Fujiwara, Eri Matsubara, Taro Nishikawa, Yoshito Ihara, Kenji Uchimura, Naoyuki Iwahashi, Takuro Sakagami, Makoto Suzuki, Yoshihiro Komoha |
| Chromothripsis is a novel biomarker for prognosis and differentiation diagnosis of pancreatic neuroendocrine neoplasms. MedComm 2024 7 5 (7): e623. Ming-Yi Zhang, Du He, Yi Zhang, Ke Cheng, Hong-Shuai Li, Yu-Wen Zhou, Qiong-Xian Long, Rui-Zhi Liu, Ji-Yan L |
| Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Lung cancer (Amsterdam, Netherlands) 2024 6 194 107864. Oscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, Eunice Romero-Nuñez, José Lucio-Lozada, Cesar Castillo-Ruiz, Karla Acevedo-Castillo, Rosa María Álvarez-Gómez, Carolina Molina-Garay, Marco Jiménez-Olivares, Karol Carrillo-Sánchez, Elvia Cristina Mendoza-Caamal, Andrés F Cardona, Jordi Remon, Carmen Alaez-Vers |
| Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast cancer (Tokyo, Japan) 2024 6 . Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, William F Symmans, Julia F Hopkins, Lee A Albacker, Antonello Abbattista, Kay Noonan, Marielena Mata, A Douglas Laird, Joanne L Bl |
| HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers. International journal of molecular sciences 2024 5 25 (9): . Nicola Di-Iacovo, Simona Ferracchiato, Stefania Pieroni, Damiano Scopetti, Marilena Castelli, Danilo Piobbico, Luca Pierucci, Marco Gargaro, Davide Chiasserini, Giuseppe Servillo, Maria Agnese Della-Faz |
| Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO precision oncology 2024 4 8 e2300634. Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati, Colin C Pritchard, Michael C Haffner, Todd Yezefski, Jessica E Hawley, Heather H Cheng, Evan Y Yu, Petros Grivas, Robert B Montgomery, Peter S Nelson, Delphine L Chen, Thomas Hope, Amir Iravani, Michael T Schweiz |
| Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia 2024 4 . Christopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, Natalia Estrada, Friederike Christen, Ute Martha Moll, Robert Zeillinger, Wolfgang Daniel Schmitt, Jalid Sehouli, Hagen Kulbe, Maximilian Fleischmann, Isabelle Ray-Coquard, Alain Zeimet, Francesco Raspagliesi, Claudio Zamagni, Ignace Vergote, Domenica Lorusso, Nicole Concin, Lars Bullinger, Elena Ioana Braicu, Frederik Da |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
| Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
- Page last reviewed:Feb 1, 2024
- Content source: